McPherson RA, Pincus MR. Henry’s clinical diagnosis and management by laboratory methods. Vol 21. Philadelphia, PA: WB Saunders; 2006.Search in Google Scholar
Abbas AK, Lichtman AH, Pillai S. Cellular and molecular immunology. Vol 6. Philadelphia, PA: WB Saunders; 2007.Search in Google Scholar
Boxer LA. How to approach neutropenia. Hematology Am Soc Hematol Educ Program 2012;2012:174–82.10.1182/asheducation.V2012.1.174.3798251Search in Google Scholar
Andrès E, Maloisel F. Idiosyncratic drug-induced agranulocytosis or acute neutropenia. Curr Opin Hematol 2008;15:15–21.10.1097/MOH.0b013e3282f15fb9Search in Google Scholar
Tesfa D, Keisu M, Palmblad J. Idiosyncratic drug-induced agranulocytosis: possible mechanisms and management. Am J Hematol 2009;84:428–34.10.1002/ajh.21433Search in Google Scholar
Mintzer DM, Billet SN, Chmielewski L. Drug-induced hematologic syndromes. Adv Hematol 2009;2009:495863.10.1155/2009/495863Search in Google Scholar
Andrès E, Federici L, Weitten T, Vogel T, Alt M. Recognition and management of drug-induced blood cytopenias: the example of drug-induced acute neutropenia and agranulocytosis. Expert Opin Drug Saf 2008;7:481–9.10.1517/14740338.7.4.481Search in Google Scholar
Stroncek DF. Drug-induced immune neutropenia. Transfus Med Rev 1993;7:268–74.10.1016/S0887-7963(93)70146-7Search in Google Scholar
Bhatt V, Saleem A. Review: drug-induced neutropenia— pathophysiology, clinical features, and management. Ann Clin Lab Sci 2004;34:131–7.Search in Google Scholar
[No authors listed] Risks of agranulocytosis and aplastic anemia: a first report of their relation to drug use with special reference to analgesics: the International Agranulocytosis and Aplastic Anemia Study. JAMA 1986;256:1749–57.10.1001/jama.256.13.1749Search in Google Scholar
Ibañez L, Vidal X, Ballarin E, Laporte JR. Population-based drug-induced agranulocytosis. Arch Intern Med 2005;165: 869–74.10.1001/archinte.165.8.86915851637Search in Google Scholar
van Staa TP, Boulton F, Cooper C, Hagenbeek A, Inskip H, Leufkens HG. Neutropenia and agranulocytosis in England and Wales: incidence and risk factors. Am J Hematol 2003; 72:248–54.10.1002/ajh.1029512666135Search in Google Scholar
van der Klauw MM, Goudsmit R, Halie MR, et al. A population-based case-cohort study of drug-associated agranulocytosis. Arch Intern Med 1999;159:369–74.10.1001/archinte.159.4.36910030310Search in Google Scholar
Berliner N, Horwitz M, Loughran TP Jr. Congenital and acquired neutropenia. Hematology Am Soc Hematol Educ Program 2004:63–79.10.1182/asheducation-2004.1.63Search in Google Scholar
Cooper DS. Antithyroid drugs. N Engl J Med 1984;311: 1353–62.10.1056/NEJM198411223112106Search in Google Scholar
Tajiri J, Noguchi S, Murakami T, Murakami N. Antithyroid drug-induced agranulocytosis. The usefulness of routine white blood cell count monitoring. Arch Intern Med 1990;150: 621–4.10.1001/archinte.1990.00390150107020Search in Google Scholar
Pai MP, Mercier RC, Koster SA. Epidemiology of vancomycin-induced neutropenia in patients receiving home intravenous infusion therapy. Ann Pharmacother 2006;40:224–8.10.1345/aph.1G436Search in Google Scholar
Rosenthal M, Breysse Y, Dixon AS, et al. Levamisole and agranulocytosis. Lancet 1977;1:904–5.10.1016/S0140-6736(77)91227-2Search in Google Scholar
Zhu NY, Legatt DF, Turner AR. Agranulocytosis after consumption of cocaine adulterated with levamisole. Ann Intern Med 2009;150:287–9.10.7326/0003-4819-150-4-200902170-0010219153405Search in Google Scholar
Czuchlewski DR, Brackney M, Ewers C, et al. Clinicopathologic features of agranulocytosis in the setting of levamisole-tainted cocaine. Am J Clin Pathol 2010;133:466–72.10.1309/AJCPOPQNBP5THKP120154286Search in Google Scholar
Dahl O, Fluge O, Carlsen E, et al. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group. Acta Oncol 2009;48:368–76.10.1080/0284186090275524419242829Search in Google Scholar
Wolford A, McDonald TS, Eng H, et al. Immune-mediated agranulocytosis caused by the cocaine adulterant levamisole: a case for reactive metabolite(s) involvement. Drug Metab Dispos 2012;40:1067–75.10.1124/dmd.112.04502122393119Search in Google Scholar
Williams DP, Pirmohamed M, Naisbitt DJ, Uetrecht JP, Park BK. Induction of metabolism-dependent and -independent neutrophil apoptosis by clozapine. Mol Pharmacol 2000;58: 207–16.10.1124/mol.58.1.20710860943Search in Google Scholar
Bux J, Kober B, Kiefel V, Mueller-Eckhardt C. Analysis of granulocyte-reactive antibodies using an immunoassay based upon monoclonal-antibody-specific immobilization of granulocyte antigens. Transfus Med 1993;3:157–62.10.1111/j.1365-3148.1993.tb00055.xSearch in Google Scholar
Stroncek DF, Herr GP. The chemical and immunoglobulin structural features necessary for reactions of quinine-dependent antibodies to neutrophils. Transfusion 1995;35: 247–53.10.1046/j.1537-2995.1995.35395184282.xSearch in Google Scholar
Gottschall JL, Neahring B, McFarland JG, Wu GG, Weitekamp LA, Aster RH. Quinine-induced immune thrombocytopenia with hemolytic uremic syndrome: clinical and serological findings in nine patients and review of literature. Am J Hematol 1994;47:283–9.10.1002/ajh.2830470407Search in Google Scholar
Meyer O, Gaedicke G, Salama A. Demonstration of drug-dependent antibodies in two patients with neutrophenia and successful treatment with granulocyte-colony-stimulating factor. Transfusion 1999;39:527–30.10.1046/j.1537-2995.1999.39050527.xSearch in Google Scholar
Stroncek DF, Shankar RA, Herr GP. Quinine-dependent antibodies to neutrophils react with a 60-Kd glycoprotein on which neutrophil-specific antigen NB1 is located and an 85-Kd glycosyl-phosphatidylinositol-linked N-glycosylated plasma membrane glycoprotein. Blood 1993;81:2758–66.10.1182/blood.V81.10.2758.2758Search in Google Scholar
Hou M, Horney E, Stockelberg D, Jacobsson S, Kutti J, Wadenvik H. Multiple quinine-dependent antibodies in a patient with episodic thrombocytopenia, neutropenia, lymphocytopenia, and granulomatous hepatitis. Blood 1997;90:4806–11.10.1182/blood.V90.12.4806Search in Google Scholar
Bougie DW, Benito AI, Sanchez-Abarca LI, Torres R, Birenbaum J, Aster RH. Acute thrombocytopenia caused by sensitivity to the glucuronide conjugate of acetaminophen. Blood 2007;109:3608–9.10.1182/blood-2006-12-063941Search in Google Scholar
Cunha PD, Lord RS, Johnson ST, Wilker PR, Aster RH, Bougie DW. Immune hemolytic anemia caused by sensitivity to a metabolite of etodolac, a nonsteroidal anti-inflammatory drug. Transfusion 2000;40:663–8.10.1046/j.1537-2995.2000.40060663.xSearch in Google Scholar
Salama A, Schütz B, Kiefel V, Breithaupt H, Mueller-Eckhardt C. Immune-mediated agranulocytosis related to drugs and their metabolites: mode of sensitization and heterogeneity of antibodies. Br J Haematol 1989;72:127–32.10.1111/j.1365-2141.1989.tb07672.xSearch in Google Scholar
Pisciotta AV. Drug-induced agranulocytosis. Peripheral destruction of polymorphonuclear leukocytes and their marrow precursors. Blood Rev 1990;4:226–37.10.1016/0268-960X(90)90002-ASearch in Google Scholar
Dekant W. The role of biotransformation and bioactivation in toxicity. EXS 2009;99:57–86.10.1007/978-3-7643-8336-7_319157058Search in Google Scholar
Ries CA, Rosenbaum TJ, Garratty G, Petz LD, Fudenberg HH. Penicillin-induced immune hemolytic anemia. Occurrence of massive intravascular hemolysis. JAMA 1975;233:432–5.10.1001/jama.1975.03260050038017Search in Google Scholar
Aster RH. Drug-induced immune cytopenias. Toxicology 2005;209:149–53.10.1016/j.tox.2004.12.03115767027Search in Google Scholar
Uetrecht J. Idiosyncratic drug reactions: past, present, and future. Chem Res Toxicol 2008;21:84–92.10.1021/tx700186p18052104Search in Google Scholar
Samlowski WE, Frame RN, Logue GL. Flecanide-induced immune neutropenia. Documentation of a hapten-mediated mechanism of cell destruction. Arch Intern Med 1987;147: 383–4.10.1001/archinte.1987.00370020201066Search in Google Scholar
Hargis JB, La Russa VF, Redmond J, Kessler SW, Wright DG. Agranulocytosis associated with “Mexican aspirin” (dipyrone): evidence for an autoimmune mechanism affecting multipotential hematopoietic progenitors. Am J Hematol 1989; 31:213–15.10.1002/ajh.28303103142741915Search in Google Scholar
Masuda A, Yoshida M, Shiomi H, et al. Role of Fc receptors as a therapeutic target. Inflamm Allergy Drug Targets 2009;8: 80–6.10.2174/187152809787582525399035819275696Search in Google Scholar
Abramson JS, Wheeler JG. The neutrophil. New York, NY: Oxford University Press; 1993.Search in Google Scholar
Aster RH. Can drugs cause autoimmune thrombocytopenic purpura? Semin Hematol 2000;37:229–38.10.1053/shem.2000.8954Search in Google Scholar
Murphy MF, Riordan T, Minchinton RM, et al. Demonstration of an immune-mediated mechanism of penicillin-induced neutropenia and thrombocytopenia. Br J Haematol 1983; 55:155–60.10.1111/j.1365-2141.1983.tb01233.x6882683Search in Google Scholar
Berkman EM, Orlin JB, Wolfsdorf J. An anti-neutrophil antibody associated with a propylthiouracil-induced lupus-like syndrome. Transfusion 1983;23:135–8.10.1046/j.1537-2995.1983.23283172851.x6836692Search in Google Scholar
